2,0
25 okt 2010
Voormalige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Great benefits, wealth of tools and training to do your job, reasonably stable company
Minpunten
Company stability in question with patent expiration and Roche take over. Even before this, advancement, outside of core biotech, correlated only with connections or whether you represented a desired demographic niche. Now, that's doubly true.